Skip to content
StockMarketAgent
Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

SOLV stock hub

Solventum Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SOLVis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
12.7B
NYSE
Market data

Live price

Current market quote for this ticker.

Current price
SOLV
In the news

Latest news · SOLV

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E10.9
P25 12.6P50 18.3P75 33.7
Trailing P/E9
P25 15P50 23.3P75 38.5
ROE34.8
P25 -106.6P50 -46.9P75 -3.1
ROIC5.6
P25 -63.1P50 -27.5P75 -0
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SOLV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
228
Groups with data
11
Currency
USD
Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0001964738
Company name
Solventum Corporation
Country
United States
Country code
US
Cusip
83444M101
Employees
20,584
Employees Change
-1,416%
Employees Change Percent
-6.44
Enterprise value
$17.4B
Exchange
NYSE
Financial currency
USD
First seen
2026-05-09
In Index
SP500
Industry
Medical Instruments & Supplies
Isin
US83444M1018
Last refreshed
2026-05-10
Market cap
$12.7B
Market cap category
Large-Cap
Price
$73.38
Price currency
USD
Rev Per Employee
401,379.71x
Sector
Healthcare
Sic
3841
Symbol
SOLV
Website
https://www.solventum.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
11.27%
EV Earnings
12.18x
EV Sales Forward
2.07x
EV/EBIT
27.72x
EV/EBITDA
15.51x
EV/Sales
2.11x
FCF yield
-1.6%
Forward P/E
10.93x
P/B ratio
2.56x
P/E ratio
8.99x
P/S ratio
1.54x
PE Ratio3 Y
16.98x
PEG ratio
1.11x
PS Forward
1.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

21
MetricValue
EBIT Margin
7.61%
EBITDA Margin
13.6%
Gross margin
53.66%
Gross Profit
$4.4B
Gross Profit Growth
-2.87%
Gross Profit Growth Q
-2.4%
Gross Profit Growth3 Y
-1.32%
Net Income
$1.4B
Net Income Growth
277.84%
Net Income Growth Q
-90.51%
Net Income Growth Years
1%
Net Income Growth3 Y
3.66%
Pretax Margin
20.47%
Profit Margin
17.33%
Profit Per Employee
$69,569
Profitable Years
5
ROA
2.75
ROCE
5.85
ROE
34.8
ROIC
5.57
Roic5y
9.73

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr1y
12.06%
EPS Growth
275.1
EPS Growth Q
-91.03
EPS Growth Years
1
EPS Growth3 Y
3.13
OCF Growth
-80.44%
OCF Growth3 Y
-56.38%
Revenue Growth
-0.55x
Revenue Growth Q
-3.04x
Revenue Growth Years
3x
Revenue Growth3 Y
0.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
$0.58
Assets
$14.1B
Cash
$561M
Current Assets
$3.6B
Current Liabilities
$3.3B
Debt
$5.3B
Debt EBITDA
$4.25
Debt Equity
$1.06
Equity
$5B
Interest Coverage
2.06
Liabilities
$9.1B
Long Term Assets
$10.5B
Long Term Liabilities
$5.8B
Net Cash
$-4.7B
Net Cash By Market Cap
$-37.21
Net Debt EBITDA
$4.21
Net Debt Equity
$0.95
Tangible Book Value
$-3.2B
Tangible Book Value Per Share
$-18.18
WACC
6.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.07
Inventory Turnover
3.92
Net Working Capital
$181M
Quick ratio
0.52
Working Capital
$237M
Working Capital Turnover
$22.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-0.72%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
12.05%
200-day SMA
73.79
50-day SMA
67.67
50-day SMA vs 200-day SMA
50under200
All Time High
96.05
All Time High Change
-23.6%
All Time High Date
2024-03-26
All Time Low
47.16
All Time Low Change
55.6%
All Time Low Date
2024-07-16
ATR
2.05
Beta
0.65
Beta1y
1.08
Beta2y
0.67
Ch YTD
-7.4
High
73.4
High52
88.2
High52 Date
2025-12-02
High52ch
-16.8%
Low
71.5
Low52
62.38
Low52 Date
2026-04-07
Low52ch
17.63%
Ma50ch
8.44%
Price vs 200-day SMA
-0.56%
RSI
66.72
RSI Monthly
52.99
RSI Weekly
51.21
Sharpe ratio
0.4x
Sortino ratio
0.81
Total Return
-0.72%
Tr YTD
-7.4
Tr1m
17.43%
Tr1w
10.13%
Tr3m
-6.07%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

17
MetricValue
Analyst Count
12
Analyst Count Top
2
Analyst Price Target Top
$84
Analyst Ratings
Buy
Analyst Ratings Top
Buy
Earnings EPS Estimate
$1.35
Earnings EPS Estimate Growth
0.75
Earnings Revenue Estimate
1,975,071,632x
Earnings Revenue Estimate Growth
-4.59x
Operating Income
$629M
Operating Income Growth
-27.78
Operating Income Growth Q
-30
Operating Income Growth3 Y
-26.93
Operating margin
7.61
Price target
$85.27
Price Target Change
$16.2
Price Target Change Top
$14.47

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
146,979,553%
Float Percent
84.87%
Net Borrowing
-2,924,000,000
Shares Insiders
0.21%
Shares Institutions
75.7%
Shares Out
173,174,712
Shares Qo Q
-0.11%
Shares Yo Y
0.72%
Short Float
4.34%
Short Ratio
4.49
Short Shares
3.69

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

66
MetricValue
Adjusted FCF
$-366M
Average Volume
1,265,793x
Bv Per Share
28.63
CAPEX
$-354M
Ch1m
17.43
Ch1w
10.13
Ch1y
12.05
Ch3m
-6.07
Ch6m
2.6
Change
2.41%
Change From Open
2.12
Close
71.65
Days Gap
0.29
Depreciation Amortization
495,000,000
Dollar Volume
123,422,224.8
Earnings Date
2026-05-05
Earnings Time
amc
EBIT
$629M
EBITDA
$1.1B
EPS
$8.16
F Score
5
FCF
$-203M
FCF EV Yield
-1.16x
FCF Per Share
$-1.17
Financing CF
-2,968,000,000
Fiscal Year End
December
Founded
2,023
Goodwill
5,626,000,000
Graham Number
72.52571
Graham Upside
-1.16
Income Tax
$259M
Investing CF
2,834,000,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-05
Last Report Date
2026-03-31
Last Split Type
Never
Last10k Filing Date
2026-02-27
Lynch Fair Value
$40.82
Lynch Upside
-44.37
Ma150
74.11
Ma150ch
-0.99%
Ma20
69.04
Ma20ch
6.29%
Net CF
26,000,000
Next Earnings Date
2026-08-06
Open
71.86
Optionable
Yes
P OCF Ratio
84.16
Position In Range
98.95
Post Close
73.38
Postmarket Change Percent
-1.94
Postmarket Price
$71.96
Ppne
1,729,000,000
Price Date
2026-05-08
Price EBITDA
$11.31
Relative Volume
1.33x
Revenue
8,262,000,000x
SBC By Revenue
1.97x
Share Based Comp
163,000,000
Tax By Revenue
3.13x
Tax Rate
15.32%
Tr6m
2.6%
Us State
Minnesota
Volume
1,681,960
Z Score
1.77
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does SOLV pay a dividend?

Capital-return profile for this ticker.

Performance

SOLV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+12.0%
S&P 500 1Y: n/a
3Y total return
n/a
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns SOLV?

Insider, institutional, and short-interest positioning.

Institutional ownership
+75.7%
Float: +84.9% of shares outstanding
Insider ownership
+0.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+4.3%
4.5 days to cover
Y/Y dilution
+0.7%
Negative means the company is buying back shares.
Technical

SOLV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
66.7
Neutral momentum band
Price vs 200-day MA
-0.6%
50/200-day relationship not available
Beta (5Y)
0.65
Less volatile than the market
Sharpe ratio
0.40
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SOLV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SOLV stock rating?

Solventum Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SOLV analysis?

The full report lives at /stocks/SOLV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SOLV?

The latest report frames SOLV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SOLV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.